CTT Pharmaceutical Holdings, Inc. (CTTH)

CTTH Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2014	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2014	Feb 28, 2014	Dec 31, 2013
Net Income	-0.15	-0.25	-0.04	-0.67	-0.02	-0.02
Depreciation & Amortization	0.01	0.01	0.01	-	-	-
Stock-Based Compensation	-0.14	-	-	0.55	-	-
Other Operating Activities	-0	-	-	0.07	0	0.01
Change in Accounts Payable	-0.01	0.02	0	-0.01	0.01	0.01
Change in Other Net Operating Assets	-	-	-	-0.01	-	-
Operating Cash Flow	-0.29	-0.23	-0.03	-0.07	-0	-0
Cash Acquisitions	-	-	-	0.15	-	-
Investing Cash Flow	-0	-	-	0.15	-	-
Short-Term Debt Issued	-	-	-	-	0	-
Long-Term Debt Issued	-	0.02	0.01	-	-	-
Total Debt Issued	0.11	0.02	0.01	-	0	-
Long-Term Debt Repaid	-	-0.01	-	-	-	-
Net Debt Issued (Repaid)	0.1	0.01	0.01	-	0	-
Issuance of Common Stock	0.22	0.22	0.08	-	-	-
Repurchase of Common Stock	-	-	-0.07	-	-	-
Other Financing Activities	0	0	-	-	-	-
Financing Cash Flow	0.32	0.23	0.02	-	0	-
Foreign Exchange Rate Adjustments	-	-	-	0	-	0
Miscellaneous Cash Flow Adjustments	0	-	-	-	-	-
Net Cash Flow	0.03	0	-0.01	0.08	0	-
Levered Free Cash Flow	-	-	-	-	0	-
Unlevered Free Cash Flow	-	-	-	-	0	-
Change in Working Capital	-0.01	0.02	0	-0.02	0.01	0.01

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.